Actinium Pharmaceuticals, Inc. (ATNM)
Stock-Based Compensation
$237.00K
TTM · Period ending: · USD
ATNM Stock-Based Compensation
Latest reported$237.00Kperiod ending
Latest reported$237.00Kperiod ending
ATNM TTM Stock-Based Comp ($0.00 → $237.00K)
TTM stock-based compensation
High-resolution chart · PNG
ATNM stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 237,000 | |
| 316,000 | |
| 9,190,000 | |
| 10,383,000 | |
| 11,611,000 | |
| 12,788,000 | |
| 5,292,000 | |
| 5,016,000 | |
| 4,600,000 | |
| 4,227,000 | |
| 2,849,000 | |
| 2,901,000 | |
| 2,950,000 | |
| 2,374,000 | |
| 2,795,000 | |
| 2,264,000 | |
| 1,705,000 | |
| 1,280,000 | |
| 1,235,000 | |
| 1,171,000 | |
| 1,048,000 | |
| 1,258,000 | |
| 1,254,000 | |
| 1,181,094 | |
| 1,283,638 | |
| 1,350,318 | |
| 1,294,707 | |
| 1,370,565 | |
| 1,385,960 | |
| 1,535,105 | |
| 1,798,655 | |
| 2,051,334 | |
| 2,327,216 | |
| 3,043,061 | |
| 3,493,731 | |
| 4,074,064 | |
| 4,407,772 | |
| 4,343,550 | |
| 4,297,778 | |
| 3,831,637 | |
| 3,949,686 | |
| 5,138,292 | |
| 7,061,622 | |
| 7,366,755 | |
| 8,313,706 | |
| 7,437,870 | |
| 6,280,629 | |
| 5,595,114 | |
| 3,610,556 | |
| 2,314,538 | |
| 657,812 | |
| 2,508,297 | |
| 2,484,426 | |
| 2,430,636 | |
| 2,536,426 | |
| 312,500 | |
| 240,400 | |
| 199,990 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |